DERM

Journey Medical Corporation

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$4.39

Price (1 Year)

$8.68 $4.39

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %19.5 / %30
Non-compliant assets / Total market cap %0 / %30
Non-compliant revenue / Total income %0.9 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris.

Website

Analysis (Turkish): DERM Hissesi Caiz mi, Helal mi? Journey Medical Corporation Katılım Analizi